• Business
    • Financial
      • Banking & Insurance
      • Company Earnings
      • Corporate Finance
      • Credit Markets
      • Economic News
      • Equity Issues
      • Financial Research
      • IPO Talk
      • Personal Finance
      • Private Equity
      • Stock Picks
    • Agriculture
    • Business Failures
    • Business Stories
    • Entertainment
    • Company News
    • High-Tech
    • Media
    • Food & Dining
    • Industries
    • Mergers & Acquisitions
    • Natural Resources & Energy
    • Security & Defense
    • Food & Dining
    • Shareholder Activism
    • Retail
    • Sports
    • Transportation & Cars
  • Trump Report Daily
  • Politics
    • Business
    • Religion
    • Terrorism
    • Media
    • Government
    • Israel-Palestine
    • Elections
    • International
    • Anti-Semitism
    • Trump Presidency
    • Trump Administration
    • War
  • Real Estate
    • Fashion & Cosmetics
    • Hotels
    • Office
    • Retail, industrial and commercial
    • Sport & Entertainment
    • Residential
  • Court
    • Law Suits
    • Crime
  • NewsMakers & The A List
    • Business leaders
    • Politicians
    • scientists & thinker
    • The A-List
  • Technology & StartUps
    • Apps
    • Bio-Tech
    • From Around The World
    • Gadgets
    • Gaming
    • Technology
    • Security & Defence
    • StartUps
    • Venture Capital
  • New Research
    • Earth History
    • Health
    • Space
  • Culture & Art
    • Entertainment
    • Art
    • Books
    • History
    • Movies
    • Music
    • Television & Radio
    • Theatre
  • Life & Style
    • Celebs
    • Celebrity Homes
    • Horoscope
    • Just Business Talking
    • Life
    • Health
    • Philanthropy
    • Sports
    • Travel
  • News Briefs
  • Opinion & Articles
    • Articles
    • Jewish Thought
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Jewish Business News
  • Business
    • Financial
      • Banking & Insurance
      • Company Earnings
      • Corporate Finance
      • Credit Markets
      • Economic News
      • Equity Issues
      • Financial Research
      • IPO Talk
      • Personal Finance
      • Private Equity
      • Stock Picks
    • Agriculture
    • Business Failures
    • Business Stories
    • Entertainment
    • Company News
    • High-Tech
    • Media
    • Food & Dining
    • Industries
    • Mergers & Acquisitions
    • Natural Resources & Energy
    • Security & Defense
    • Food & Dining
    • Shareholder Activism
    • Retail
    • Sports
    • Transportation & Cars
  • Trump Report Daily
  • Politics
    • Business
    • Religion
    • Terrorism
    • Media
    • Government
    • Israel-Palestine
    • Elections
    • International
    • Anti-Semitism
    • Trump Presidency
    • Trump Administration
    • War
  • Real Estate
    • Fashion & Cosmetics
    • Hotels
    • Office
    • Retail, industrial and commercial
    • Sport & Entertainment
    • Residential
  • Court
    • Law Suits
    • Crime
  • NewsMakers & The A List
    • Business leaders
    • Politicians
    • scientists & thinker
    • The A-List
  • Technology & StartUps
    • Apps
    • Bio-Tech
    • From Around The World
    • Gadgets
    • Gaming
    • Technology
    • Security & Defence
    • StartUps
    • Venture Capital
  • New Research
    • Earth History
    • Health
    • Space
  • Culture & Art
    • Entertainment
    • Art
    • Books
    • History
    • Movies
    • Music
    • Television & Radio
    • Theatre
  • Life & Style
    • Celebs
    • Celebrity Homes
    • Horoscope
    • Just Business Talking
    • Life
    • Health
    • Philanthropy
    • Sports
    • Travel
  • News Briefs
  • Opinion & Articles
    • Articles
    • Jewish Thought
Jewish Business News Jewish Business News
Home Tags Dr. Michael Hayden

Tag: Dr. Michael Hayden

Teva finds double-dose Copaxone halves side-effects

Jewish Business News Correspondent - September 11, 2014 0

Teva Reports Positive Phase III Asthma Drug Results

Jewish Business News Correspondent - September 2, 2014 1
CFO Eyal Desheh, TEVA

Analysts Unenthusiastic Over Teva’s NTE Products

Shiri Habib-Valdhorn - December 5, 2013 0
CFO Eyal Desheh, TEVA

Teva Acting CEO Eyal Desheh: Teva Has 13 New Therapeutic Entities...

Adi Ben-Israel - October 31, 2013 0
OPKO

Teva acquires MicroDose Therapeutx for $40 million and further payments of...

Jewish Business News Correspondent - June 17, 2013 1
Jewish Business News
ABOUT US
Jewish Business News it the leading publication covering worldwide jewish and jewish-related business news
Contact us: [email protected]
FOLLOW US